Showing results (1231-1240 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|August 30, 2021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort studyKatherine A Twohig, Tommy Nyberg, Asad Zaidi, et al.
The Lancet. Infectious Diseases|March 9, 2023
Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trialEliézer K N'Goran, Maurice R Odiere, Ronald Assandé Aka, et al.
The Lancet. Infectious Diseases|November 17, 2022
Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trialOlivier Marcy, Eric Wobudeya, Hélène Font, et al.
The Lancet. Infectious Diseases|November 18, 2022
Déjà vu all over again? Monkeypox and the urgent need for randomised controlled trialsDavid A Lindholm, Andre C Kalil
The Lancet. Infectious Diseases|March 1, 2025
Development of the Mycetoma Activity and Severity clinical Scale (MASS): an international Delphi studyDavid J Chandler, Gail Davey, Roderick J Hay, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and developmentJulia T Ostrowsky, Leah C Katzelnick, Nigel Bourne, et al.
The Lancet. Infectious Diseases|February 20, 2025
Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled, non-inferiority trialVerena Moos, Justina Krüger, Kristina Allers, et al.
The Lancet. Infectious Diseases|February 16, 2025
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASMOliver A Cornely, Rosanne Sprute, Matteo Bassetti, et al.
The Lancet. Infectious Diseases|February 13, 2025
Targeting the SARS-CoV-2 reservoir in long COVIDAmy D Proal, Soo Aleman, Morgane Bomsel, et al.
Pageof 271